196 related articles for article (PubMed ID: 19140848)
21. Impact of cardiovascular risk factors and inflammatory status on urinary 8-OHdG in essential hypertension.
Roselló-Lletí E; de Burgos FG; Morillas P; Cortés R; Martínez-Dolz L; Almenar L; Grigorian L; Orosa P; Portolés M; Bertomeu V; Rivera M
Am J Hypertens; 2012 Feb; 25(2):236-42. PubMed ID: 22052073
[TBL] [Abstract][Full Text] [Related]
22. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers.
Haack M; Pollmächer T; Mullington JM
Brain Behav Immun; 2004 Jul; 18(4):361-7. PubMed ID: 15157953
[TBL] [Abstract][Full Text] [Related]
23. Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma.
Ahluwalia MS; Bou-Anak S; Burgett ME; Sarmey N; Khosla D; Dahiya S; Weil RJ; Bae E; Huang P; McGraw M; Grove LM; Olman MA; Prayson RA; Suh JH; Gillespie GY; Barnholtz-Sloan J; Nowacki AS; Barnett GH; Gladson CL
J Neurooncol; 2017 Feb; 131(3):449-458. PubMed ID: 27858267
[TBL] [Abstract][Full Text] [Related]
24. The role of soluble TNF receptors for TNF-alpha in uveitis.
Sugita S; Takase H; Taguchi C; Mochizuki M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3246-52. PubMed ID: 17591895
[TBL] [Abstract][Full Text] [Related]
25. Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study.
Sveaas SH; Berg IJ; Provan SA; Semb AG; Olsen IC; Ueland T; Aukrust P; Vøllestad N; Hagen KB; Kvien TK; Dagfinrud H
Scand J Rheumatol; 2015; 44(2):118-24. PubMed ID: 25756521
[TBL] [Abstract][Full Text] [Related]
26. Both serum receptors of tumor necrosis factor are influenced by mud pack treatment in osteoarthrotic patients.
Bellometti S; Galzigna L; Richelmi P; Gregotti C; Bertè F
Int J Tissue React; 2002; 24(2):57-64. PubMed ID: 12182234
[TBL] [Abstract][Full Text] [Related]
27. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy.
Himmerich H; Beitinger PA; Fulda S; Wehrle R; Linseisen J; Wolfram G; Himmerich S; Gedrich K; Wetter TC; Pollmächer T
Arch Intern Med; 2006 Sep; 166(16):1739-43. PubMed ID: 16983052
[TBL] [Abstract][Full Text] [Related]
28. Soluble tumor necrosis factor receptor 2 is independently associated with pulse wave velocity in nonobese Japanese patients with type 2 diabetes mellitus.
Ohgushi M; Taniguchi A; Fukushima M; Nakai Y; Kuroe A; Ohya M; Nagasaka S; Taki Y; Yoshii S; Matsumoto K; Yamada Y; Inagaki N; Seino Y
Metabolism; 2007 Apr; 56(4):571-7. PubMed ID: 17379019
[TBL] [Abstract][Full Text] [Related]
29. Effects of treatment on soluble tumour necrosis factor receptor type 1 and 2 in chronic periodontitis.
Ikezawa-Suzuki I; Shimada Y; Tai H; Komatsu Y; Tanaka A; Yoshie H
J Clin Periodontol; 2008 Nov; 35(11):961-8. PubMed ID: 18823344
[TBL] [Abstract][Full Text] [Related]
30. Human soluble tumor necrosis factor receptor I (sTNF-RI) and interleukin-I receptor antagonist (IL-I Ra) in different stages of acute rheumatic fever.
Kütükçüler N; Karaca NE; Sözeri BY; Koturoğlu G; Kurugöl Z; Ozyürek RA; Aksu G
Anadolu Kardiyol Derg; 2008 Apr; 8(2):139-42. PubMed ID: 18400635
[TBL] [Abstract][Full Text] [Related]
31. [Level of soluble tumor necrosis factor receptor type I in patients with systemic scleroderma].
Alekperov RT; Timchenko AV; Samsonov MIu; Guseva NG; Nasonov EL
Ter Arkh; 2004; 76(5):11-5. PubMed ID: 15230124
[TBL] [Abstract][Full Text] [Related]
32. TNF and sTNFR1/2 plasma levels in ALS patients.
Cereda C; Baiocchi C; Bongioanni P; Cova E; Guareschi S; Metelli MR; Rossi B; Sbalsi I; Cuccia MC; Ceroni M
J Neuroimmunol; 2008 Feb; 194(1-2):123-31. PubMed ID: 18083240
[TBL] [Abstract][Full Text] [Related]
33. Plasma TNF binding capacity in patients with juvenile idiopathic arthritis.
Bjørnhart B; Svenningsen P; Gudbrandsdottir S; Zak M; Nielsen S; Bendtzen K; Müller K
Int Immunopharmacol; 2005 Jan; 5(1):73-7. PubMed ID: 15589462
[TBL] [Abstract][Full Text] [Related]
34. Preoperative clinical factors are important determinants of the inflammatory state before and after heart surgery.
Magovern JA; Singh D; Teekell-Taylor L; Scalise D; McGregor W
ASAIO J; 2007; 53(3):316-9. PubMed ID: 17515721
[TBL] [Abstract][Full Text] [Related]
35. Effects of soluble TNF receptor II (sTNF-RII), IL-1 receptor antagonist (IL-1ra), tumor load and hypermetabolism on malnutrition in children with acute leukemia.
Schmid I; Schmitt M; Streiter M; Meilbeck R; Haas RJ; Stachel DK
Eur J Med Res; 2005 Nov; 10(11):457-61. PubMed ID: 16354598
[TBL] [Abstract][Full Text] [Related]
36. Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study.
Marti CN; Khan H; Mann DL; Georgiopoulou VV; Bibbins-Domingo K; Harris T; Koster A; Newman A; Kritchevsky SB; Kalogeropoulos AP; Butler J;
Circ Heart Fail; 2014 Jan; 7(1):5-11. PubMed ID: 24323631
[TBL] [Abstract][Full Text] [Related]
37. Elevation of soluble tumor necrosis factor receptor II in non-febrile patients with acute myeloid leukemia.
Goetz M; Schiel X; Heussel H; Steinmetz T; Hiddemann W; Weiss M
Eur J Med Res; 2002 Nov; 7(11):487-90. PubMed ID: 12568977
[TBL] [Abstract][Full Text] [Related]
38. Systemic soluble tumor necrosis factor receptors 1 and 2 are associated with severity of diabetic retinopathy in Hispanics.
Kuo JZ; Guo X; Klein R; Klein BE; Cui J; Rotter JI; Ipp E; Chen YD
Ophthalmology; 2012 May; 119(5):1041-6. PubMed ID: 22330960
[TBL] [Abstract][Full Text] [Related]
39. Time of interferon-beta 1a injection and duration of treatment affect clinical side effects and acute changes of plasma hormone and cytokine levels in multiple sclerosis patients.
Kümpfel T; Schwan M; Pollmächer T; Yassouridis A; Uhr M; Trenkwalder C; Weber F
Mult Scler; 2007 Nov; 13(9):1138-45. PubMed ID: 17967841
[TBL] [Abstract][Full Text] [Related]
40. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
Grünhage F; Rezori B; Neef M; Lammert F; Sauerbruch T; Spengler U; Reichel C
Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1255-62. PubMed ID: 18995216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
